00353nas a2200097   4500000000100000008004100001100001500042245017900057300001200236490000700248       2020                            d1 aK Mahaffey00aDedicated kidney disease-focused outcome trials with sodium-glucose cotransporter-2 inhibitors: Lessons from CREDENCE and expectations from DAPA-HF, DAPA-CKD, and EMPA-KIDNEY  a46 - 540 v22